Synthekine and Sanofi collaborate on IL-10 receptor agonists for inflammatory diseases
Jan. 30, 2024
Synthekine Inc. has established a worldwide collaboration with Sanofi SA to develop and commercialize IL-10 receptor agonists for the treatment of inflammatory diseases.